KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on May 07, 2026 - 2:41PM >>  ABB India 7256  [ 1.05% ]  ACC 1422.8  [ 0.53% ]  Ambuja Cements 447.1  [ 0.11% ]  Asian Paints 2523.4  [ 0.18% ]  Axis Bank 1297.8  [ 0.13% ]  Bajaj Auto 10529.3  [ 2.08% ]  Bank of Baroda 269.5  [ -0.48% ]  Bharti Airtel 1827.9  [ -0.30% ]  Bharat Heavy 392.4  [ 1.66% ]  Bharat Petroleum 307.2  [ -2.21% ]  Britannia Industries 5770.5  [ -0.20% ]  Cipla 1374.7  [ 0.69% ]  Coal India 470  [ 0.05% ]  Colgate Palm 2161.75  [ 0.22% ]  Dabur India 464.95  [ -0.30% ]  DLF 610.5  [ 0.24% ]  Dr. Reddy's Lab. 1312.2  [ 0.13% ]  GAIL (India) 166.8  [ 0.69% ]  Grasim Industries 2942.7  [ 1.06% ]  HCL Technologies 1185.5  [ -0.29% ]  HDFC Bank 793.2  [ -0.43% ]  Hero MotoCorp 5333.95  [ 3.18% ]  Hindustan Unilever 2294  [ -1.04% ]  Hindalco Industries 1051.25  [ 0.47% ]  ICICI Bank 1290.15  [ 0.84% ]  Indian Hotels Co. 669.15  [ 0.47% ]  IndusInd Bank 942.5  [ -0.42% ]  Infosys 1169.35  [ 0.18% ]  ITC 309.9  [ -0.23% ]  Jindal Steel 1266  [ 0.13% ]  Kotak Mahindra Bank 380.3  [ 1.09% ]  L&T 4006.6  [ -0.04% ]  Lupin 2478.15  [ 1.47% ]  Mahi. & Mahi 3358  [ 1.76% ]  Maruti Suzuki India 13741.55  [ 0.15% ]  MTNL 31.89  [ 0.09% ]  Nestle India 1477.65  [ -0.59% ]  NIIT 74.76  [ 1.14% ]  NMDC 90.7  [ 1.68% ]  NTPC 397.8  [ 0.79% ]  ONGC 283.65  [ 1.05% ]  Punj. NationlBak 109.45  [ -0.64% ]  Power Grid Corpn. 314.65  [ -0.35% ]  Reliance Industries 1441.65  [ 0.26% ]  SBI 1093.9  [ -0.16% ]  Vedanta 312.85  [ -1.12% ]  Shipping Corpn. 315.75  [ 0.99% ]  Sun Pharmaceutical 1834.6  [ -0.85% ]  Tata Chemicals 823.55  [ 0.85% ]  Tata Consumer 1142.8  [ -0.83% ]  Tata Motors Passenge 358.35  [ 0.10% ]  Tata Steel 217  [ 0.67% ]  Tata Power Co. 440.15  [ -0.64% ]  Tata Consult. Serv. 2415  [ -0.84% ]  Tech Mahindra 1458.4  [ -0.58% ]  UltraTech Cement 12162.5  [ 0.57% ]  United Spirits 1293.1  [ 0.06% ]  Wipro 198.55  [ -0.28% ]  Zee Entertainment 94.9  [ 0.39% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

SUPRIYA LIFESCIENCE LTD.

07 May 2026 | 02:19

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE07RO01027 BSE Code / NSE Code 543434 / SUPRIYA Book Value (Rs.) 140.59 Face Value 2.00
Bookclosure 05/09/2025 52Week High 832 EPS 23.35 P/E 30.11
Market Cap. 5659.55 Cr. 52Week Low 546 P/BV / Div Yield (%) 5.00 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
The Company was incorporated as `Supriya Lifescience Limited' pursuant to a certificate of incorporation dated March 26, 2008 issued by the Registrar of Companies, Maharashtra at Mumbai ("RoC"), upon the conversion of `M/s Supriya Chemicals', a partnership firm, into a public limited company, in accordance with the provisions of Part IX of the Companies Act, 1956. the Company commenced operations pursuant to a certificate for commencement of business dated April 1, 2008 issued by the RoC.

Major events and milestones of the Company :
2008
- Incorporation of the Company upon its conversion from a partnership firm to a public limited company

2009
- Started production of Ketamine Hydrochloride

2010
- CEP (Certificate of Sustainability) granted for Chlorphenamine Maleate

2011
- IDL granted for Chlorphenamine Maleate

2013
- COFEPRIS and KFDA approval granted

2014
- USFDA approval granted
- IDL granted for Brompheniramine Maleate

2015
- EUGMP and EDQM approval granted

2017
- CEP (Certificate of Sustainability) granted for Pheniramine Maleate
- Second time USFDA approval granted

2018
- CEP (Certificate of Sustainability) granted for Brompheniramine Maleate, Mepyramine Maleate & Ketamine Hydrochloride

2020
- Third time USFDA approval

2021
- CEP (Certificate of Suitability) granted for Pentoxifylline, Esketamine Hydrochloride and Salbutamol Sulphate
- NMPA approval granted
- Health Canada approval

2022
-Supriya Lifescience Limited has informed the Exchange regarding 'Intimation Regarding Captive Solar Project Agreement Signed with Enrich Energy Pvt. Ltd'.

2024
-"Supriya Lifescience Ltd Inaugurates State-of-the-Art Module E Production Block at Lote Parshuram, Maharashtra". -Supriya Lifescience inaugurates Rs 125 crore API production block at Lote Parshuram site.

2025
-Supriya Lifescience honoured with Maharashtra State Export Award for two consecutive years
-Supriya Lifescience Secures WHO GMP Certification for Ambernath Facility